Farxiga is a prescription drug used to treat type 2 diabetes, heart failure, and kidney disease in certain adults. It’s also approved to help manage type 2 diabetes in some children. Some people may ...
WILMINGTON, Del.--(BUSINESS WIRE)--New data from a sub-analysis of the landmark Phase III DAPA-HF (Dapagliflozin And Prevention of Adverse-outcomes in Heart Failure) trial showed that AstraZeneca’s ...
Indication: As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. The FDA has approved Farxiga (dapagliflozin) to reduce the risk of cardiovascular ...
WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca has been granted Fast Track Designation in the US for the development of FARXIGA ® (dapagliflozin) to reduce the risk of hospitalization for heart ...
London, UK, Friday 30 May 2025 – Today, AstraZeneca announced that the National Institute for Health and Care Excellence (NICE) has published updated Final Draft Guidance recommending Forxiga ...
Treatment with dapagliflozin led to a statistically significant improvement in HbA1c compared with placebo. The Food and Drug Administration (FDA) has expanded the approval of Farxiga ® (dapagliflozin ...
Farxiga can cost between $400 and $600 without insurance, depending on the pharmacy and whether a person buys the brand drug or the generic. Whether Medicare can pay a share of this cost depends on ...
Taking Farxiga with medications like insulin or diuretics may cause low blood sugar, dehydration, or low blood pressure, requiring monitoring and possible dosage adjustments by your doctor. Farxiga ...
AstraZeneca’s Forxiga (dapagliflozin) has been approved in China to reduce the risk of cardiovascular (CV) death and hospitalisation for heart failure (hHF) in adults with heart failure (NYHA class II ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results